Background. Cardiovascular autonomic neuropathy (CAN) is recognized as a significant health risk. Specific and
sensitive measures of CAN are needed for early identification and treatment to avoid complications, preferably
in the preclinical state.
Objectives. In this first of two articles, the patient cohort is described and two measures of autonomic function are reviewed: the traditional heart rate variability (HRV)-alone method and the newer parasympathetic and sympathetic (P&S) Method. These systems are then evaluated against known effects of the alpha/beta-adrenergic blocker, Carvedilol, and the selective beta-adrenergic blocker, Metoprolol, on P&S activity.
Methods. Serial autonomic nervous system test data from 147 type 2 diabetes mellitus patients from eight ambulatory clinics were analyzed. Patients were grouped according to whether a beta-blocker was (1) introduced, (2) discontinued or (3) continued without adjustment. Group 3 served as the control. HRV-alone parameters are computed according to standards. The P&S Method, which is a time–frequency analyses of concurrent respiratory activity and HRV, is elucidated, as developed at MIT and Harvard Medical School (1981).
Results. The HRV-alone demonstrated that introducing either medication increased low frequency (msec2) and standard deviation of the beat-to-beat (N-N) interval (msec), as expected. The other HRV parameter responses were not consistent with expectations. Similar inconsistencies occurred when either medication was discontinued. The P&S Method demonstrated that introducing or discontinuing either agent decreased or increased sympathetic activity, respectively, according to expectations. With ongoing treatment, resting parasympathetic activity decreased with Metoprolol but increased with Carvedilol.
Conclusion. Autonomic assessment fidelity was significantly higher with the P&S Method as validated by comparison with previously known physiology of the cardiovascular system.
Beta-blocker, Cardiac autonomic neuropathy, Heart rate variability, Patient outcomes, Respiratory analysis, Sympathovagal imbalance
Financial support: None.
Dr. Joe Colombo 240 South Eighth Street Philadelphia, PA, USA 19107 email@example.com
Share this Article
Related Content In Arrhythmia
Spontaneously Recanalized Coronary Thrombus in the Left Anterior Descending Artery Presenting as Ventricular Tachycardia
Heart International. 2020;14(2):123-8 DOI: https://doi.org/10.17925/HI.2020.14.2.123
Spontaneously recanalized coronary thrombus (SRCT), informally known as Swiss-cheese, honeycomb, lotus root or spiderweb lesion, is an increasingly recognised pathology in patients undergoing coronary angiography. Most patients with SRCT present with angina or angina equivalent.1 We describe a case of SRCT in a patient who presented with ventricular tachycardia (VT) without a previous history of ischaemic […]
Prolonged Extracorporeal Membrane Oxygenation Support In a Patient with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome-associated Fulminant Myocarditis – A Case Report and Literature Review
Heart International. 2020;14(2):112-7 DOI: https://doi.org/10.17925/HI.2020.14.2.112
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe cutaneous adverse drug reaction. Symptoms comprise fever, lymphadenopathy, rash, and eosinophilia, with or without visceral organ involvement. The extent of internal organ involvement, including hepatitis, myocarditis, pneumonitis, thyroiditis, and pancreatitis, determines the morbidity and mortality associated with the disease.1–3 We report a case of […]
Atrial Fibrillation and Dementia
European Journal of Arrhythmia & Electrophysiology. 2020;6(1):10-6 DOI: https://doi.org/10.17925/EJAE.2020.6.1.10
Atrial fibrillation (AF) is one of the most common arrhythmias. It affected 33.5 million people worldwide in 2010, a number that is expected to double by 2050.1 AF prevalence increases with age, and approximately 25% of individuals aged 40 years or older will develop AF during their lifetime.2,3 Irrespective of age, AF incidence also increases with diabetes […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!